Laxative Ingredient Pediatric Study Provides Compass For FDA Action
This article was originally published in The Tan Sheet
Executive Summary
FDA supports research to evaluate long-term exposure of polyethylene glycol 3350 in children, saying “pharmacokinetic data from pediatric patients would provide better information” on the ingredient’s safety. A consumer group that petitioned FDA for a black box warning has additional questions.